Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sudeep Pharma Limited Call Transcript 2026

Feb 2, 2026

59914_rns_2026-02-02_875792f6-0658-4e77-ad2e-16f1cc81354f.pdf

Call Transcript

Open in viewer

Opens in your device viewer

Date: 02[nd ] February, 2026

==> picture [152 x 86] intentionally omitted <==

To,

National Stock Exchange of India Limited BSE Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Bandra Kurla Dalal Street, Mumbai – 400001 Complex, Bandra (E), Mumbai – 400051 Scrip Code: 544619 Scrip Symbol- SUDEEPPHRM

Sub: Intimation of Earnings Call with Analysts/Investors on 09[th] February 2026

Ref: Regulation 30 of the SEBI Listing Regulations, 2015

Dear Sir/Ma’am,

This is to inform that the “Earnings Call” of the Company with Analysts/Investors to discuss the operational & financial performance for the quarter and nine ended on December 31, 2025, is scheduled as below:

Day & Date: Monday, 09[th] February 2026

Time: 11:30 a.m., IST

Registration Link and Access numbers: As per Annexure

Copy of Earnings Call invite is annexed herewith and is also hosted on our website https://www.sudeeppharma.com/.

Kindly take the same on record.

Thanking You.

For Sudeep Pharma Limited

DIMPLE Digitally signed by DIMPLE ASHWINBHAIMEHTA ASHWINBHAI DN: cn=DIMPLE ASHWINBHAI MEHTA, c=IN,st=Gujarat, o=Personal, title=8748, serialNumber=be901a7b4cfd5ff4b6e3310581e MEHTA 678582e8fcab3536586c4a365ba53eccbf1a6 Date: 2026.02.02 15:24:34 +05'30' Dimple Mehta Company Secretary & Compliance Officer M. No.: F13184

ENCL: A/a

CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: [email protected]

==> picture [74 x 64] intentionally omitted <==

==> picture [90 x 60] intentionally omitted <==

==> picture [133 x 47] intentionally omitted <==

Sudeep Pharma Limited Conference Call

Monday, 9 February 2026 at 11:30am IST

We are organising a conference call with the management of Sudeep Pharma Limited, to discuss the company’s business strategy and outlook post the declaration of its Q3FY26 results.

Management participants**Mr. Sujit Bhayani,**Managing Director**Mr. Shanil Bhayani,**Director**Mr. Ketan Vyas,**Chief Financial OfficerDate / TimeMonday, 9 February 2026 at 11:30am IST(HK/Singapore – 2:00pm, UK – 6:00am, New York – 1:00am)Diamond PassEventLink Management participants**Mr. Sujit Bhayani,**Managing Director**Mr. Shanil Bhayani,**Director**Mr. Ketan Vyas,**Chief Financial OfficerDate / TimeMonday, 9 February 2026 at 11:30am IST(HK/Singapore – 2:00pm, UK – 6:00am, New York – 1:00am)Diamond PassEventLink Management participants**Mr. Sujit Bhayani,**Managing Director**Mr. Shanil Bhayani,**Director**Mr. Ketan Vyas,**Chief Financial OfficerDate / TimeMonday, 9 February 2026 at 11:30am IST(HK/Singapore – 2:00pm, UK – 6:00am, New York – 1:00am)Diamond PassEventLink Management participants**Mr. Sujit Bhayani,**Managing Director**Mr. Shanil Bhayani,**Director**Mr. Ketan Vyas,**Chief Financial OfficerDate / TimeMonday, 9 February 2026 at 11:30am IST(HK/Singapore – 2:00pm, UK – 6:00am, New York – 1:00am)Diamond PassEventLink
Date / Time Monday, 9 February(HK/Singapore – 2:0 026 at 11:30am IST0pm UK – 6:00am New York –
, ,
Diamond Pass
EventLink
India
Universal Access+91 22 6280 1259 / +91 22 7115 8160InternationalToll-free numberUSA18667462133UK08081011573Singapore8001012045
121
USAUK 86674633
08081011573
Singapore 8001012045
HongKong 800964448

For further information, please contact:

Ranjit Cirumalla | Tel: +91 22 4646 4654 | Email: [email protected]

IIFL – 24th floor, One Lodha Place, Senapati Bapat Marg, Lower Parel (W), Mumbai 400 013, Tel: (91-22) 4646 4600, Fax: (91-22) 4646 4700